BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Thursday, February 5, 2026
Home » targets

Articles Tagged with ''targets''

Illustration of motor neuron connecting to muscle fiber
Neurology/Psychiatric

Loss of cyclin D3 function reduces DMD pathogenesis in mdx mouse model

June 29, 2023
Duchenne muscular dystrophy (DMD) is an X-linked genetic disorder affecting roughly 1 in 3,500 males. DMD is due to mutations in the dystrophin gene, which encodes for an exceptionally large 427 kD protein. DMD is characterized by repeated degeneration and regeneration of muscle fibers, but ultimately replacement of muscle with fibrotic and adipose tissue. Despite advances in gene therapy and improvements in quality of life, most patients still die by 30 years of age due to cardiopulmonary failure.
Read More
Diagnostics

TSHR-targeted PET imaging using newly developed radiopharmaceutical [89Zr]Zr-TR1402

June 28, 2023
Ninety-five percent of the thyroid cancer diagnoses are differentiated thyroid cancers (DTC) with...
Read More
Colorized scanning electron microscope image of an osteosarcoma cell.
Immuno-oncology

Characterization of osteosarcoma-detecting MAb leads to identification of ALPL-1 as a CAR T target for treating osteosarcoma

June 27, 2023
Osteosarcomas (OS) are the most common malignant bone tumor. The disease originates within the fastest growing areas of the long bones of children and young adults, where the histologic hallmark of OS is malignant bone formation (osteoid). Improvements in treatments have proven difficult to date with metastatic OS remaining a bleak prognosis routinely leading to lung metastases to ultimately cause death.
Read More
Heme in red blood cells
Hematologic

NLRP12 senses heme plus PAMPs to trigger PANoptosis, aggravate hemolytic disease

June 21, 2023
Identification of the mechanisms of innate immune sensors is fundamental to the understanding of health and disease. The pattern recognition receptor (PRR) subfamily of nucleotide-binding oligomerization domain (NOD)-like receptors (NLRs) work by recognizing either pathogen-associated molecular patterns (PAMPs), endogenous damage-associated molecular patterns (DAMPs) or associated molecular...
Read More
Nephrology

HDAC9 inhibitors may be an effective therapeutic approach for chronic kidney disease

June 20, 2023
Chronic kidney disease (CKD) is the 10th leading cause of death in the United States because of the increased risk for cardiovascular mortality. The major functional cell type of the kidney, tubular epithelial cells (TECs), possess a limited ability to regenerate tissues. Infections can cause proximal G2/M cell cycle arrest, senescence and paracrine secretion of the profibrotic cytokines transforming growth factor-β1 (TGF-β1) and connective tissue growth factor (CTGF), which stimulate extracellular matrix production ultimately leading to loss of the epithelial phenotype in TECs. Identification of targets controlling the G2/M cell cycle arrest in TECs may enable the development of therapeutics that can prevent CKD progression.
Read More
Creative rendition of SARS-CoV-2 virus particles.
Infection

Inhibition of aryl hydrocarbon receptor reduces SARS-CoV-2 replication, ameliorates COVID-19 pathology

June 19, 2023
Having caused over 6.2 million deaths globally ongoing, the COVID-19 pandemic since 2020 continues to pose a serious public health challenge. While the SARS-CoV-2 receptors angiotensin-converting enzyme 2 (ACE2) and transmembrane protease serine 2 play requisite roles in permitting the initial infection, up to 10 proviral host factors have also been determined to play crucial roles in controlling the viral replication, but most are not pharmacologically targetable.
Read More
Cancer

Targeting of RNA-editing enzyme ADAR1 overcomes chemotherapeutic drug-resistant gastric cancer

June 16, 2023
Gastric cancer (GC) is the fourth most common cause of cancer-related deaths, causing more than 750,000 deaths in 2020. Platinum-based 5-fluorouracil (5-FU) combinations improve survival times compared to surgery alone, but emergent treatment resistance limits long-term clinical benefits. Accordingly, there is an urgent need to develop alternative approaches to overcoming chemoresistance.
Read More
Pediatric brain illustration
Neurology/Psychiatric

Efna2 and Cx43 in brain capillary endothelial cells affect age-dependent La Crosse virus-induced neurological disease

June 14, 2023
La Crosse virus (LACV) is one of the most common causes of arboviral encephalitis in children, which causes CNS damage owing to infection in children, but not adults. LACV pathology indicates significant breakdown of the blood-brain barrier, which is strengthened during developmental transition from child to adult.
Read More
Cancer cells being destroyed by immunotherapy
Immuno-oncology

Targeting PRMT1 inhibits cGAS-mediated suppression of antitumor immunity, shows promise for combination immunotherapy

June 14, 2023
Cyclic GMP-AMP synthase (cGAS) converts ATP and GTP into 2′3′-cyclic GMP-AMP (cGAMP), which serves as a second messenger, binding...
Read More
Cancer

CEBPG as a novel transcriptional regulator of ferroptosis in ovarian cancer

June 6, 2023
Researchers from Xinhua Hospital have published data from a study that aimed to assess the role of CEBPG, an important regulator of tumor development, in the progression of ovarian cancer (OC).
Read More
Previous 1 2 … 37 38 39 40 41 42 43 44 45 … 53 54 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Feb. 4, 2025.
  • Today's news in brief

    Briefs
    BioWorld MedTech briefs for Jan. 30, 2026.
  • Art concept for medical research

    MicroRNAs in circulating extracellular vesicles as IPF biomarkers

    BioWorld Science
    MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
  • Brain illustration

    MJFF grant supports Bexorg’s translational biomarker work

    BioWorld Science
    Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
  • Brain and DNA

    REST emerges as biomarker in ALS, knockdown improves ALS symptoms

    BioWorld Science
    About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing